Physician profile
David R Ormond
NPI 1700159555
$4,153.41
in general payments reported to CMS, 2019-2025
12 companies · $1,511 in 2025
The $1,511 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $64.99 · 2021: $91.45 · 2022: $80.91 · 2023: $1,732 · 2024: $54.30 · 2025: $1,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,159 · Food and Beverage: $1,083 · Education: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,158.80 |
| Food and Beverage | $1,082.75 |
| Education | $1,056.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Longeviti Neuro Solutions INC | $1,531.99 | 2023-2024 | |
| Aesculap, INC. | $1,408.80 | 2025 | Xabo |
| Depuy Synthes Sales INC. | $633.16 | 2019-2025 | Expedium, Fibergraft Bg Morsels, Symphony |
| Brainlab, INC. | $205.96 | 2019 | |
| Agios Pharmaceuticals, INC. | $184.60 | 2019 | |
| Zimmer Biomet Holdings, INC. | $110.59 | 2019 | |
| Gt Medical Technologies, INC | $61.25 | 2025 | Gammatile |
| Bk Medical Holding Company INC. | $17.06 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ormond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.